Being Patient editors round up a selection of our top reader submissions and Patient Perspectives of 2020. Stories from the Being Patient Community Eugenia…
Scientists are barreling toward a future in which, thanks to CRISPR, it is possible to edit the genetic make-up of brain cells to prevent…
Alzheimer’s disease is more prevalent among Black Americans than among white Americans. By some estimates, it is 14% more common among Black Americans; by others, their…
While researchers have known that the ApoE4 genetic variant is the strongest genetic risk factor for Alzheimer’s and related dementias, this finding is largely…
Researchers in Germany studied the effects of ApoE4, the best known genetic factor for Alzheimer’s Disease, on the brains of 82 young adults —…
As many as one third of dementia cases may be preventable with lifestyle changes, but a recent survey finds that many Americans are not…
Alzheimer’s main hallmarks — beta-amyloid plaques and tau tangles — have long been the focus of the quest to come up with an Alzheimer’s…
Protein plaques and tangles have long been thought to be the cause of Alzheimer’s disease. Now, scientists are looking beyond those biomarkers at a…
New research has uncovered proteins coded by genes of the female sex chromosome that may explain why women are more resilient to the disease….
Can a gene that naturally suppresses Alzheimer’s in brain cells pave the way to curing it? In 2012, excitement rippled through the scientific community…
A new study published in International Journal of Molecular Sciences (IJMS) links certain enzymes with degenerative brain diseases, which could mean scientists and drugmakers now…
The Alzheimer’s gene, known as ApoE4, is one of the the largest genetic risk factors for later onset Alzheimer’s disease. Carrying one copy of the…
Frustrated for decades with failure after failure in efforts to find effective medications to treat Alzheimer’s and other cognitive disorders, researchers are now increasingly…
Researchers have identified a gene called Presenilin1, or PSEN1, as a potential new biomarker for Alzheimer’s disease. In mice and human samples, the researchers…
Scientists in London have identified a type of genetic mutation that appears to protect against late-onset Alzheimer’s disease. For their paper, published in the…